dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Argilés Martinez, Guillem |
dc.contributor.author | Sobrero, Alberto |
dc.contributor.author | Borg, Christophe |
dc.contributor.author | Ohtsu, Atsushi |
dc.contributor.author | Mayer, Robert |
dc.date.accessioned | 2021-09-20T13:10:54Z |
dc.date.available | 2021-09-20T13:10:54Z |
dc.date.issued | 2020-08-19 |
dc.identifier.citation | Tabernero J, Argiles G, Sobrero AF, Borg C, Ohtsu A, Mayer RJ, et al. Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis. ESMO Open. 2020 Aug 19;5:e000752. |
dc.identifier.issn | 2059-7029 |
dc.identifier.uri | https://hdl.handle.net/11351/6334 |
dc.description | Quimioterapia; Metástasis; Pronóstico |
dc.language.iso | eng |
dc.publisher | BMJ |
dc.relation.ispartofseries | ESMO Open;5 |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Còlon - Càncer |
dc.subject | Recte - Càncer |
dc.subject | Quimioteràpia combinada |
dc.subject.mesh | Colorectal Neoplasms |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.subject.mesh | /therapeutic use |
dc.title | Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/esmoopen-2020-000752 |
dc.subject.decs | neoplasias colorrectales |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://doi.org/10.1136/esmoopen-2020-000752 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Tabernero J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, Barcelona, Catalunya, Spain. Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Argiles G] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, IOB-Quiron, Barcelona, Catalunya, Spain. Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Sobrero AF] Medical Oncology Ospedale Policlinico San Martino Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia. [Borg C] Department of Medical Oncology, University Hospital Centre Besançon, Besancon, Bourgogne Franche-Comté, France. [Ohtsu A] Kashiwa, National Cancer Center-Hospital East, Kashiwa, Chiba, Japan. [Mayer RJ] Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA |
dc.identifier.pmid | 32817131 |
dc.identifier.wos | 000564366600005 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |